Wegovy pill sales smash forecasts, sending Novo Nordisk stock 7% higher
Novo Nordisk raised its outlook for 2026 after a strong performance from its newly launched Wegovy pill.
AI brief
Pulse reads the full article- What happened
- Why it matters
- What to watch
Sign in to get the AI brief. Pulse explains what happened, why it matters, what to watch and who's exposed. Free for members.
Sign in to read the brief
